CytoDyn Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
CytoDyn Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q3 2024.
  • CytoDyn Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending August 31, 2024 was 1.14B shares, a 22.9% increase year-over-year.
  • CytoDyn Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 970M shares, a 15.9% increase from 2022.
  • CytoDyn Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 837M shares, a 23.6% increase from 2021.
  • CytoDyn Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 677M shares, a 15.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 1.14B +211M +22.9% Jun 1, 2024 Aug 31, 2024 10-Q 2024-10-15
Q2 2024 970M +133M +15.9% Mar 1, 2024 May 31, 2024 10-K 2024-08-15
Q1 2024 982M +150M +18% Dec 1, 2023 Feb 29, 2024 10-Q 2024-04-15
Q4 2023 959M +146M +17.9% Sep 1, 2023 Nov 30, 2023 10-Q 2024-01-16
Q3 2023 924M +136M +17.2% Jun 1, 2023 Aug 31, 2023 10-Q 2024-10-15
Q2 2023 837M +160M +23.6% Mar 1, 2023 May 31, 2023 10-K 2024-08-15
Q1 2023 832M +137M +19.6% Dec 1, 2022 Feb 28, 2023 10-Q 2024-04-15
Q4 2022 813M +151M +22.8% Sep 1, 2022 Nov 30, 2022 10-Q 2024-01-16
Q3 2022 788M +155M +24.5% Jun 1, 2022 Aug 31, 2022 10-Q 2023-10-23
Q2 2022 677M Mar 1, 2022 May 31, 2022 10-K 2023-09-14
Q1 2022 696M +695M Dec 1, 2021 Feb 28, 2022 10-Q 2023-04-10
Q4 2021 663M Sep 1, 2021 Nov 30, 2021 10-Q 2023-01-09
Q3 2021 633M Jun 1, 2021 Aug 31, 2021 10-Q/A 2022-10-13
Q1 2021 578K* Dec 1, 2020 Feb 28, 2021 10-Q 2022-04-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.